CHESHIRE, Conn. (AP) _ Alexion Pharmaceuticals Inc. (ALXN) on Thursday reported first-quarter profit of $91.3 million.
The Cheshire, Connecticut-based company said it had net income of 45 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.28 per share.
The results did not meet Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.32 per share.
The drugmaker posted revenue of $600.3 million in the period, exceeding Street forecasts. Ten analysts surveyed by Zacks expected $592.4 million.
Alexion expects full-year earnings in the range of $5.60 to $5.80 per share.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALXN at http://www.zacks.com/ap/ALXN